All Updates

All Updates

icon
Filter
Funding
Cradle raises USD 24 million in Series A funding for team expansion
AI Drug Discovery
Nov 28, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Nov 28, 2023

Cradle raises USD 24 million in Series A funding for team expansion

Funding

  • Switzerland-based AI biotech startup Cradle has secured USD 24 million in a Series A funding round led by Index Ventures, with participation from Kindred Capital, Chris Gibson, Tom Glocer, and other existing investors. This brings the total funds raised by the company to USD 33 million.

  • The proceeds will be utilized to expand the team, boost sales, and construct additional engineering and lab facilities. 

  • Founded in 2022, Cradle is involved in designing proteins using GenAI that focus on understanding molecular structures, allowing a quicker, more cost-effective process of protein design. The firm employs natural language processing and proprietary data to anticipate alterations needed in the protein's genetic code for enhanced function and stability. The company also offers AI-assisted design tools that can predict a protein’s 3D structure, generate new sequences with improved thermostability and optimize codons. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.